Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Lazarovici
Towy Sorel
TS
Department of Oral and Maxillofacial Surgery, Sheba Medical Center, Tel Hashomer, Israel. towy_lazarovici@yahoo.com
Yahalom
Ran
R
Taicher
Shlomo
S
Schwartz-Arad
Devorah
D
Peleg
Oren
O
Yarom
Noam
N
D000284:Administration, Oral; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003758:Dental Implantation, Endosseous / Q000009:adverse effects*; D015921:Dental Implants / Q000009:adverse effects*; D020878:Device Removal; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010020:Osteonecrosis / Q000188:drug therapy / Q000209:etiology*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D050071:Bone Density Conservation Agents; D015921:Dental Implants; D004164:Diphosphonates; D004318:Doxycycline